{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:04:31Z","timestamp":1789193071959,"version":"build-2803163510"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Hypertension is the most prevalent cardiovascular disorder and the leading cause of death worldwide in both sexes. The prevalence of hypertension is lower in premenopausal women than in men of the same age, but sharply increases after the menopause, resulting in higher rates in women aged 65 and older. Awareness, treatment, and control of hypertension are better in women. A sex-pooled analysis from 4 community-based cohort studies found increasing cardiovascular risk beginning at lower systolic blood pressure thresholds for women than men. Hormonal changes after the menopause play a substantial role in the pathophysiology of hypertension in postmenopausal women. Female-specific causes of hypertension such as the use of contraceptive agents and assisted reproductive technologies have been identified. Hypertensive disorders in pregnancy are associated with increased risk of maternal, fetal, and neonatal morbidity and mortality, as well as with a greater risk of developing cardiovascular disease later in life. Hypertension-mediated organ damage was found to be more prevalent in women, thus increasing the cardiovascular risk. Sex differences in pharmacokinetics have been observed, but their clinical implications are still a matter of debate. There are currently no sufficient data to support sex-based differences in the efficacy of antihypertensive treatment. Adverse drug reactions are more frequently reported in women. Women are still underrepresented in large clinical trials in hypertension, and not all of them report sex-specific results. Therefore, it is of utmost importance to oblige scientists to include women in clinical trials and to consider sex as a biological variable.<\/jats:p>","DOI":"10.3389\/fcvm.2022.960336","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T05:52:41Z","timestamp":1661233961000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Sex differences in hypertension. Do we need a sex-specific guideline?"],"prefix":"10.3389","volume":"9","author":[{"given":"Renata","family":"C\u00edfkov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larysa","family":"Strilchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD","year":"2018","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.79.1.1","volume":"79","year":"1987","journal-title":"Pediatrics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"Eur Heart J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1161\/HYP.0000000000000066","article-title":"ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1503\/cmaj.101863","article-title":"Diagnosed hypertension in Canada: incidence, prevalence and associated mortality","volume":"184","author":"Robitaille","year":"2012","journal-title":"CMAJ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/HJH.0b013e32834d9eda","article-title":"Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10\/66 cross-sectional population-based survey","volume":"30","author":"Prince","year":"2012","journal-title":"J Hypertens."},{"key":"B12","first-page":"10","article-title":"The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III","volume":"4","author":"Martins","year":"2001","journal-title":"J Gend Specif Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/eurjpc\/zwaa144","article-title":"Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry","volume":"29","author":"Vynckier","year":"2022","journal-title":"Eur J Prev Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"100230","DOI":"10.1016\/j.ajpc.2021.100230","article-title":"Age and sex disparities in hypertension control: the multi-ethnic study of atherosclerosis (MESA)","volume":"8","author":"Osude","year":"2021","journal-title":"Am J Prev Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/CIRCULATIONAHA.120.049360","article-title":"Sex differences in blood pressure associations with cardiovascular outcomes","volume":"143","author":"Ji","year":"2021","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"E44","DOI":"10.1002\/clc.20509","article-title":"Gender-related differences in coronary artery dimensions: a volumetric analysis","volume":"33","author":"Dickerson","year":"2010","journal-title":"Clin Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/HYPERTENSIONAHA.110.156828","article-title":"Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women","volume":"57","author":"Boggia","year":"2011","journal-title":"Hypertension."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/00004872-199609000-00001","article-title":"White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next?","volume":"14","author":"Mancia","year":"1996","journal-title":"J Hypertens."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1097\/HJH.0b013e3282fbcedf","article-title":"Masked hypertension: a systematic review","volume":"26","author":"Bobrie","year":"2008","journal-title":"J Hypertens."},{"key":"B20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1161\/HYPERTENSIONAHA.113.01275","article-title":"White-coat hypertension: new insights from recent studies","volume":"62","author":"Franklin","year":"2013","journal-title":"Hypertension."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1097\/HJH.0000000000001074","article-title":"Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide Data from the ARTEMIS study","volume":"34","author":"Omboni","year":"2016","journal-title":"J Hypertens."},{"key":"B22","doi-asserted-by":"publisher","first-page":"R233","DOI":"10.1152\/ajpregu.00338.2003","article-title":"Gender, sex hormones, and vascular tone","volume":"286","author":"Orshal","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2012.07.005","article-title":"Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the multi-ethnic study of atherosclerosis","volume":"224","author":"Wang","year":"2012","journal-title":"Atherosclerosis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","article-title":"Gender and the renin-angiotensin-aldosterone system","volume":"24","author":"Komukai","year":"2010","journal-title":"Fundam Clin Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"R1220","DOI":"10.1152\/ajpregu.00864.2007","article-title":"Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition","volume":"294","author":"Sullivan","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0895-7061(03)01008-2","article-title":"Hypertension in women","volume":"17","author":"Safar","year":"2004","journal-title":"Am J Hypertens."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0735-1097(01)01166-4","article-title":"Comparative effects of aging in men and women on the properties of the arterial tree","volume":"37","author":"Smulyan","year":"2001","journal-title":"J Am Coll Cardiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1210\/endo-91-5-1227","article-title":"In vivo effects of estradiol on collagen and elastin dynamics in rat aorta","volume":"91","author":"Fischer","year":"1972","journal-title":"Endocrinology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000158172","article-title":"Effects of sex hormones on the passive mechanical properties of rat carotid artery","volume":"15","author":"Cox","year":"1978","journal-title":"Blood Vessels."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1097\/00004872-200112000-00014","article-title":"Women exhibit a greater age-related increase in proximal aortic stiffness than men","volume":"19","author":"Waddell","year":"2001","journal-title":"J Hypertens."},{"key":"B31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/01.HYP.37.2.381","article-title":"Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity","volume":"37","author":"Benetos","year":"2001","journal-title":"Hypertension."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","article-title":"Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data","volume":"4","author":"Zhu","year":"2019","journal-title":"Lancet Public Health."},{"key":"B33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/2047487314556004","article-title":"Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis","volume":"23","author":"van Lennep","year":"2016","journal-title":"Eur J Prev Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: management of women with premature ovarian insufficiency","volume":"31","author":"Webber","year":"2016","journal-title":"Hum Reprod."},{"key":"B35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2840-9-7","article-title":"Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States","volume":"9","author":"Belletti","year":"2010","journal-title":"Cardiovasc Diabetol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3s","DOI":"10.1016\/S0895-7061(99)00252-6","article-title":"Risk stratification in hypertension: new insights from the framingham study","volume":"13","author":"Kannel","year":"2000","journal-title":"Am J Hypertens."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation."},{"key":"B38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.33549\/physiolres.934068","article-title":"Selected sex related differences in pathophysiology of cardiovascular system","volume":"69","author":"Kittnar","year":"2020","journal-title":"Physiol Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40885-018-0099-z","article-title":"Metabolic syndrome, not menopause, is a risk factor for hypertension in peri-menopausal women","volume":"24","author":"Oh","year":"2018","journal-title":"Clin Hypertens."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; international atherosclerosis society; and International association for the study of obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2337\/dc10-0942","article-title":"Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk","volume":"33","author":"Kuk","year":"2010","journal-title":"Diabetes Care."},{"key":"B42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.20452\/pamw.15975","article-title":"Increase in the prevalence of metabolic syndrome in Poland: comparison of the results of the WOBASZ (2003-2005) and WOBASZ II (2013-2014) studies","volume":"131","author":"Rajca","year":"2021","journal-title":"Pol Arch Intern Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1530\/EC-17-0011","article-title":"Sex, BMI and age differences in metabolic syndrome: the Dutch lifelines cohort study","volume":"6","author":"Slagter","year":"2017","journal-title":"Endocr Connect."},{"key":"B44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/HJH.0000000000002019","article-title":"First international consensus on the diagnosis and management of fibromuscular dysplasia","volume":"37","author":"Gornik","year":"2019","journal-title":"J Hypertens."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1038\/s41467-021-26174-2","article-title":"Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases","volume":"12","author":"Georges","year":"2021","journal-title":"Nat Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/s-0030-1247545","article-title":"Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1)","volume":"42","author":"Hannemann","year":"2010","journal-title":"Horm Metab Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"E340","DOI":"10.1210\/jc.2010-1355","article-title":"Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1210\/jcem-28-9-1269","article-title":"Aldosterone secretory rates in the normal menstrual cycle","volume":"28","author":"Gray","year":"1968","journal-title":"J Clin Endocrinol Metab."},{"key":"B50","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/jcem-34-5-819","article-title":"Plasma aldosterone and renin activity during the menstrual cycle","volume":"34","author":"Katz","year":"1972","journal-title":"J Clin Endocrinol Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.119.13006","article-title":"Sex Difference in the association between subtype distribution and age at diagnosis in patients with primary aldosteronism","volume":"74","author":"Akasaka","year":"2019","journal-title":"Hypertension."},{"key":"B52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"B53","first-page":"B5232","article-title":"Endocrine and metabolic characteristics in polycystic ovary syndrome","volume":"63","author":"Glintborg","year":"2016","journal-title":"Dan Med J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.preghy.2017.12.006","article-title":"Polycystic ovary syndrome, body mass index and hypertensive disorders in pregnancy","volume":"11","author":"L\u00f8nnebotn","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"B55","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham","year":"2015","journal-title":"Am J Hypertens."},{"key":"B56","doi-asserted-by":"publisher","first-page":"E115","DOI":"10.1503\/cmaj.120677","article-title":"Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis","volume":"185","author":"Bird","year":"2013","journal-title":"Cmaj."},{"key":"B57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12958-020-00576-1","article-title":"Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"18","author":"Amiri","year":"2020","journal-title":"Reprod Biol Endocrinol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/00004872-199715100-00003","article-title":"Blood pressure in women using oral contraceptives: results from the health survey for England 1994","volume":"15","author":"Dong","year":"1997","journal-title":"J Hypertens."},{"key":"B59","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation."},{"key":"B60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischemic stroke risk with oral contraceptives: a meta-analysis","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1001\/jama.2020.11935","article-title":"Hormonal contraception in women with hypertension","volume":"324","author":"Shufelt","year":"2020","journal-title":"JAMA."},{"key":"B62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.jhh.1001841","article-title":"Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension","volume":"19","author":"Lubianca","year":"2005","journal-title":"J Hum Hypertens."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/AOG.0000000000003072","article-title":"206: use of hormonal contraception in women with coexisting medical conditions","volume":"133","author":"ACOG","year":"2019","journal-title":"Obstet Gynecol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/jch.12945","article-title":"Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis","volume":"19","author":"Thomopoulos","year":"2017","journal-title":"J Clin Hypertens."},{"key":"B65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12884-021-03938-8","article-title":"Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses","volume":"21","author":"Chih","year":"2021","journal-title":"BMC Pregnancy Childbirth."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jacc.2018.06.060","article-title":"Association of assisted reproductive technologies with arterial hypertension during adolescence","volume":"72","author":"Meister","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy478","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"B69","first-page":"170","article-title":"The impact of maternal obesity on maternal and fetal health","volume":"1","author":"Leddy","year":"2008","journal-title":"Rev Obstet Gynecol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/AOG.0000000000003082","article-title":"767 Summary: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period","volume":"133","author":"ACOG","year":"2019","journal-title":"Obstet Gynecol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"Cd002252","DOI":"10.1002\/14651858.CD002252.pub4","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"10","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/HYPERTENSIONAHA.121.18415","article-title":"Oral antihypertensives for nonsevere pregnancy hypertension: systematic review, network meta- and trial sequential analyses","volume":"79","author":"Bone","year":"2022","journal-title":"Hypertension."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N Engl J Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","article-title":"Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications","volume":"139","author":"Grandi","year":"2019","journal-title":"Circulation."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-013-9762-6","article-title":"Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis","volume":"28","author":"Brown","year":"2013","journal-title":"Eur J Epidemiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.118.11726","article-title":"Trajectory of cardiovascular risk factors after hypertensive disorders of pregnancy","volume":"73","author":"Groenhof","year":"2019","journal-title":"Hypertension."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1177\/2047487316659573","article-title":"Cardiovascular risk management after reproductive and pregnancy-related disorders: a Dutch multidisciplinary evidence-based guideline","volume":"23","author":"Heida","year":"2016","journal-title":"Eur J Prev Cardiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s12020-016-1075-6","article-title":"Hypertensive disorders during pregnancy and risk of type 2 diabetes in later life: a systematic review and meta-analysis","volume":"55","author":"Wang","year":"2017","journal-title":"Endocrine."},{"key":"B79","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/OGX.0b013e31827682fc","article-title":"Biochemical cardiovascular risk factors after hypertensive pregnancy disorders: a systematic review and meta-analysis","volume":"67","author":"Hermes","year":"2012","journal-title":"Obstet Gynecol Surv."},{"key":"B80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-0028-1103034","article-title":"The reset hypothesis: lactation and maternal metabolism","volume":"26","author":"Stuebe","year":"2009","journal-title":"Am J Perinatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/jcem.87.1.8178","article-title":"Metabolic adaptation to feeding and fasting during lactation in humans","volume":"87","author":"Tigas","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"B82","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1017\/S1368980011002102","article-title":"Prolonged breast-feeding protects mothers from later-life obesity and related cardio-metabolic disorders","volume":"15","author":"Wiklund","year":"2012","journal-title":"Public Health Nutr."},{"key":"B83","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/AOG.0b013e318297a047","article-title":"Cost analysis of maternal disease associated with suboptimal breastfeeding","volume":"122","author":"Bartick","year":"2013","journal-title":"Obstet Gynecol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/jnci\/djs505","article-title":"Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop","volume":"105","author":"Faupel-Badger","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"B85","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1089\/bfm.2018.0108","article-title":"Effect of lactation on maternal hypertension: a systematic review","volume":"13","author":"Bonifacino","year":"2018","journal-title":"Breastfeed Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/bfm.2017.0180","article-title":"Association between duration of breastfeeding and maternal hypertension: a systematic review and meta-analysis","volume":"13","author":"Qu","year":"2018","journal-title":"Breastfeed Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"138.e1","DOI":"10.1016\/j.ajog.2008.10.001","article-title":"Duration of lactation and incidence of myocardial infarction in middle to late adulthood","volume":"200","author":"Stuebe","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/01.CIR.88.4.1444","article-title":"Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events","volume":"88","author":"Devereux","year":"1993","journal-title":"Circulation."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens."},{"key":"B90","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/jhh.2010.109","article-title":"Clustering of target organ damage increases mortality after acute coronary syndromes in patients with arterial hypertension","volume":"25","author":"Cordero","year":"2011","journal-title":"J Hum Hypertens."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/HJH.0000000000000584","article-title":"Effective risk stratification in patients with moderate cardiovascular risk using albuminuria and atherosclerotic plaques in the carotid arteries","volume":"33","author":"Greve","year":"2015","journal-title":"J Hypertens."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/HYPERTENSIONAHA.107.107474","article-title":"Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan intervention for endpoint reduction in hypertension study","volume":"51","author":"Gerdts","year":"2008","journal-title":"Hypertension."},{"key":"B93","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ijcard.2017.12.086","article-title":"Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network)","volume":"258","author":"Gerdts","year":"2018","journal-title":"Int J Cardiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.116.08158","article-title":"Development of left ventricular hypertrophy in treated hypertensive outpatients: the Campania salute network","volume":"69","author":"Izzo","year":"2017","journal-title":"Hypertension."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e000144","DOI":"10.1161\/JAHA.113.000144","article-title":"Lack of reduction of left ventricular mass in treated hypertension: the strong heart study","volume":"2","author":"de Simone","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"B96","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2018.03.120","article-title":"Left atrial dilatation: a target organ damage in young to middle-age hypertensive patients. The Campania salute network","volume":"265","author":"Mancusi","year":"2018","journal-title":"Int J Cardiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/hy0302.105683","article-title":"Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study","volume":"39","author":"Gerdts","year":"2002","journal-title":"Hypertension."},{"key":"B98","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijcard.2019.10.004","article-title":"Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis","volume":"297","author":"Losi","year":"2019","journal-title":"Int J Cardiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000448454","article-title":"Arterial stiffness: recommendations and standardization","volume":"4","author":"Townsend","year":"2017","journal-title":"Pulse."},{"key":"B100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/hy0102.099031","article-title":"Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study","volume":"39","author":"Boutouyrie","year":"2002","journal-title":"Hypertension."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","article-title":"Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients","volume":"37","author":"Laurent","year":"2001","journal-title":"Hypertension."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000065428.03209.64","article-title":"Aortic stiffness is an independent predictor of fatal stroke in essential hypertension","volume":"34","author":"Laurent","year":"2003","journal-title":"Stroke."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e004271","DOI":"10.1161\/JAHA.116.004271","article-title":"Relative contributions of arterial stiffness and hypertension to cardiovascular disease: the framingham heart study","volume":"5","author":"Niiranen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B104","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.cjca.2014.03.020","article-title":"Arterial stiffness and its clinical implications in women","volume":"30","author":"Coutinho","year":"2014","journal-title":"Can J Cardiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fphar.2020.00564","article-title":"Gender differences in cardiovascular pharmacotherapy-the example of hypertension: a mini review","volume":"11","author":"Kalibala","year":"2020","journal-title":"Front Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e036418","DOI":"10.1136\/bmjopen-2019-036418","article-title":"Sex differences in the adherence of antihypertensive drugs: a systematic review with meta-analyses","volume":"10","author":"Biffi","year":"2020","journal-title":"BMJ Open."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","article-title":"Risk factors for nonadherence to antihypertensive treatment","volume":"69","author":"Gupta","year":"2017","journal-title":"Hypertension."},{"key":"B109","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1525-1497.2002.00406.x","article-title":"Non-compliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors","volume":"17","author":"Wang","year":"2002","journal-title":"J Gen Intern Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/jhh.2014.29","article-title":"Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial","volume":"29","author":"Gueyffier","year":"2015","journal-title":"J Hum Hypertens."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1097\/01.hjh.0000249692.96488.46","article-title":"Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial","volume":"24","author":"Zanchetti","year":"2006","journal-title":"J Hypertens."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/eurheartj\/ehv161","article-title":"Gender differences in the effect of cardiovascular drugs: a position document of the working group on pharmacology and drug therapy of the ESC","volume":"36","author":"Rosano","year":"2015","journal-title":"Eur Heart J."},{"key":"B113","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0828-282X(08)70624-X","article-title":"Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy","volume":"24","author":"Rabi","year":"2008","journal-title":"Can J Cardiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1093\/eurheartj\/ehn427","article-title":"Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials","volume":"29","author":"Turnbull","year":"2008","journal-title":"Eur Heart J."},{"key":"B115","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13293-020-00306-7","article-title":"Estrogen-related mechanisms in sex differences of hypertension and target organ damage","volume":"11","author":"Sabbatini","year":"2020","journal-title":"Biol Sex Differ."},{"key":"B116","doi-asserted-by":"publisher","first-page":"24955","DOI":"10.1038\/srep24955","article-title":"Systematic analysis of adverse event reports for sex differences in adverse drug events","volume":"6","author":"Yu","year":"2016","journal-title":"Sci Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00228-018-2480-y","article-title":"Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs","volume":"74","author":"Rydberg","year":"2018","journal-title":"Eur J Clin Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13293-021-00377-0","article-title":"Sex differences associated with adverse drug reactions resulting in hospital admissions","volume":"12","author":"Hendriksen","year":"2021","journal-title":"Biol Sex Differ."},{"key":"B119","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2125.2010.03811.x","article-title":"Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands","volume":"71","author":"Rodenburg","year":"2011","journal-title":"Br J Clin Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.3399\/bjgp20X712997","article-title":"Pregnancy protection and pregnancies in women prescribed ACE inhibitors or ARBs: a cross-sectional study in primary care","volume":"70","author":"Lovegrove","year":"2020","journal-title":"Br J Gen Pract."},{"key":"B121","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2459\/JCM.0000000000000315","article-title":"Arterial hypertension in the female world: pathophysiology and therapy","volume":"17","author":"Cadeddu","year":"2016","journal-title":"J Cardiovasc Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.clpt.2006.08.004","article-title":"Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent","volume":"80","author":"Th\u00fcrmann","year":"2006","journal-title":"Clin Pharmacol Ther."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e111558","DOI":"10.1371\/journal.pone.0111558","article-title":"Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program","volume":"9","author":"Franconi","year":"2014","journal-title":"PLoS ONE."},{"key":"B124","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13293-020-00308-5","article-title":"Sex differences in pharmacokinetics predict adverse drug reactions in women","volume":"11","author":"Zucker","year":"2020","journal-title":"Biol Sex Differ."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e014742","DOI":"10.1161\/JAHA.119.014742","article-title":"Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis","volume":"9","author":"Zhao","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B126","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1096\/fj.15-279554","article-title":"Studying both sexes: a guiding principle for biomedicine","volume":"30","author":"Clayton","year":"2016","journal-title":"FASEB J."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jama.202.11.1028","article-title":"Results in patients with diastolic blood pressures averaging 115 through 129 mmHg","volume":"202","year":"1967","journal-title":"JAMA"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1001\/jama.213.7.1143","article-title":"Results in patients with diastolic blood pressure averaging 90 through 114 mmHg","volume":"213","year":"1970","journal-title":"JAMA"},{"key":"B129","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1124\/pharmrev.120.000206","article-title":"Sex- and gender-based pharmacological response to drugs","volume":"73","author":"Mauvais-Jarvis","year":"2021","journal-title":"Pharmacol Rev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0033-0620(86)90038-1","article-title":"The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials","volume":"29","author":"MacMahon","year":"1986","journal-title":"Prog Cardiovasc Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1001\/jama.1979.03300230028022","article-title":"Mortality by race-sex and age. Hypertension detection and follow-up program cooperative group","volume":"242","year":"1979","journal-title":"JAMA"},{"key":"B132","doi-asserted-by":"publisher","first-page":"S597","DOI":"10.1097\/00004872-198812040-00187","article-title":"Mortality findings beyond five years in the hypertension detection and follow-up program (HDFP)","volume":"6","author":"Daugherty","year":"1988","journal-title":"J Hypertens Suppl."},{"key":"B133","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0140-6736(99)07330-4","article-title":"Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials","volume":"355","author":"Staessen","year":"2000","journal-title":"Lancet."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/HYPERTENSIONAHA.111.00213","article-title":"Mortality and morbidity during and after antihypertensive and lipid-lowering treatment to prevent heart attack trial: results by sex","volume":"61","author":"Oparil","year":"2013","journal-title":"Hypertension."},{"key":"B136","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A comparison of outcomes with angiotensin-converting\u2013enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N Engl J Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med."},{"key":"B138","first-page":"35","article-title":"Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study","volume":"3","author":"Kjeldsen","year":"2000","journal-title":"J Gend Specif Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/HYPERTENSIONAHA.108.110064","article-title":"Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy","volume":"52","author":"Okin","year":"2008","journal-title":"Hypertension."},{"key":"B140","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-126-10-199705150-00002","article-title":"Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials The INDANA Investigators","volume":"126","author":"Gueyffier","year":"1997","journal-title":"Ann Intern Med."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0895-7061(01)02211-7","article-title":"Distribution of blood pressure and hypertension in Canada and the United States","volume":"14","author":"Joffres","year":"2001","journal-title":"Am J Hypertens."},{"key":"B142","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jash.2014.08.003","article-title":"Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT","volume":"8","author":"Yamal","year":"2014","journal-title":"J Am Soc Hypertens."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.275.20.1557","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA."},{"key":"B144","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1097\/HJH.0000000000001619","article-title":"Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the systolic blood pressure intervention trial","volume":"36","author":"Foy","year":"2018","journal-title":"J Hypertens."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/00004872-200206000-00038","article-title":"Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study","volume":"20","author":"Kjeldsen","year":"2002","journal-title":"J Hypertens."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA."},{"key":"B147","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/eurheartj\/ehv598","article-title":"Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes","volume":"37","author":"Regitz-Zagrosek","year":"2016","journal-title":"Eur Heart J."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.960336\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T05:52:49Z","timestamp":1661233969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.960336\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":147,"alternative-id":["10.3389\/fcvm.2022.960336"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.960336","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"article-number":"960336"}}